Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$5.2M
4 rounds on record
Latest round
$800k
Venture round · Dec 2025 · 9 mo ago
Team
3
US Form 5500 (plan participants) · Dec 2025 · 0% in a year
Backers
1
Cortado Ventures
The money's age
Fresh money
9 months since the last round · not hiring
Momentum
20/100
fresh money
Funding rounds
RoundDateAmountInvestorsSource
Venture round Dec 2025 $800k — SEC Form D
Venture round Apr 2024 $1.5M — SEC Form D
Venture round May 2023 $1.1M — SEC Form D
Venture round Dec 2021 $1.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Glycologix, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Daniel DeardorfExecutive Officer, DirectorSEC Form D
Douglas SmithExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Make it Mighty. At MITO® Material Solutions, we believe material improvements are life improvements. As a next-generation company, we solve…
Meet the scientists behind our solutions. It's Time for a Better Way Our Founding Scientific Team Mango Materials is comprised of…
SynteticaSeries A $28.2M · 2 mo ago • Founded 2023 • 11-50 employees • 1 role
Syntetica produces virgin-quality recycled nylon using green chemistry. Transforming textile waste into sustainable Nylon 6 & 6,6 for…
Drive product success with SyBridge's precision injection molds. Full-lifecycle tooling partnership, 50+ years of expertise, global support.
RenmatixVenture round $48.6M · 6 yr ago • 201-500 employees
Finally. Affordable building blocks for the bioeconomy. Water-based chemistry for deconstructing plants into sugars and polymers.
VartegaGreen TechConvertible Note $1.5M · 9 mo ago • 51-200 employees
Vartega recycled carbon fiber (rCF) is a sustainable lower cost alternative to virgin CF for thermoplastic compounding and thermoset…

Overview

GlycoLogix - A ground-breaking therapy for Interstitial Cystitis / Bladder Pain Syndrome, developing biopolymers for soft tissue repair.

People

Daniel Deardorf
Executive Officer, Director
Douglas Smith
Executive Officer
Michael Chester
Director
George Adaniya
Director
Martha Farmer
Director
Michael Marsh
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Beverly United States
HQ
Eugene United States
Regional office
Eugene Skrabut, MS
100 Cummings Center, Suite 451C, Beverly, MA 01915
company site

Financials

Total raised
$5.2M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $800k Details
Venture - Series Unknown 2024 $1.5M Details
Venture - Series Unknown 2023 $1.1M Details
Venture - Series Unknown 2021 $1.8M Details